MedPath

Polyethylene Glycol 3350

Polyethylene Glycol 3350 NF Polyethylene Glycol 3350 Powder for Oral Solution

Approved
Approval ID

d0d2f068-4453-4ea2-8282-339b6e497a9a

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Aug 10, 2011

Manufacturers
FDA

Nexgen Pharma, Inc.

DUNS: 048488621

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Polyethylene Glycol 3350

PRODUCT DETAILS

NDC Product Code0722-6921
Application NumberANDA077706
Marketing CategoryC73584
Route of AdministrationORAL
Effective DateAugust 10, 2011
Generic NamePolyethylene Glycol 3350

INGREDIENTS (1)

POLYETHYLENE GLYCOL 3350Active
Quantity: 17 g in 1 1
Code: G2M7P15E5P
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Polyethylene Glycol 3350 - FDA Drug Approval Details